Learning Objectives:

  1. Review the Comparative ANGIOEDEMA RISK amongst ACE-I, ARB, and ARNI Drugs
  2. Analyze the Angioedema Hazard amongst De Novo Sacubitril/Valsartan Patients Versus Those Switching from Previous ACE-I or ARB Drugs

 

Robert Page, PharmD, MSPH., Presenter, has no financial relationships to disclose.

Faculty does not plan to discuss the uses of an investigational product.

 

Session date: 
03/22/2023 - 12:00pm to 1:00pm EDT
Location: 
Boston Medical Center
72 E. Concord St.
Collamore-8
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please login or register to take this course.